医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Seoul Semiconductor Will Introduce New Technologies at Automotive World 2024 to Be Held in Tokyo, Japan

2024年09月04日 AM08:00
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

Seoul Semiconductor Co., Ltd. (KOSDAQ:046890), a global optical semiconductor manufacturer, will participate in Automotive World 2024, to be held in Tokyo, Japan, starting on September 04, 2024, for the first time in its history to showcase next-generation innovative LED technologies, leading a paradigm shift in the world’s automotive market under the theme of “from a simple transportation mode to means for communication and comfort.”

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240903349776/en/

Seoul Semiconductor will be present at booth #4-38 during the Automotive World 2024 between Wednesday, September 4 and Friday, September 6 in Tokyo, Japan. (Graphic: Seoul Semiconductor Co., Ltd)

Seoul Semiconductor will be present at booth #4-38 during the Automotive World 2024 between Wednesday, September 4 and Friday, September 6 in Tokyo, Japan. (Graphic: Seoul Semiconductor Co., Ltd)

Seoul Semiconductor supplies a wide range of total auto solutions including lighting, displays, and disinfection systems. In particular, WICOP, a no-wire and no-package LED technology, makes it possible to manufacture micro and high-efficiency LEDs. As a result, it has been applied to more than 100 models by the world’s top 10 clients every year, producing impressive results backed by globally recognized technological prowess and expertise. According to LED market share data announced by Omdia, a global market research agency, in July, the company ranked No.1 in the world in the segment of backlights, attracting keen attention from potential customers in Japan.

Communication & Healthy Interior Lighting

Exhibition visitors are expected to directly witness LED technologies for automotive interior and exterior systems including WICOP-based adaptive driving beams (ADB), grille displays, and rear lamps, as well as SunLike, a healthy interior lighting source that enables users to maintain their circadian rhythm 24 hours a day with a natural spectrum, and Violeds, a disinfection technology that will protect people from the threat of viruses, all of which will be presented by Seoul Semiconductor.

Seoul Semiconductor Vice President Park In-heum, the automotive business team leader, said, “We will release our IP power product lineup for future vehicles to actively strengthen collaboration with OEMs and clients in the Japanese automotive market. This exhibition will serve as an opportunity for us to lead a paradigm shift in the world’s automotive market”

Seoul Semiconductor’s products will be exhibited at booth 4-38 during Automotive World 2024.

About Seoul Semiconductor

Seoul Semiconductor is the world’s second-largest global LED manufacturer, a ranking excluding the captive market, and has more than 18,000 patents. Based on a differentiated product portfolio, Seoul offers a wide range of technologies. Seoul Semiconductor also mass produces innovative LED products for indoor and outdoor lighting, automotive, IT products like mobile phones, computer displays, and other applications, as well as the UV area. Seoul’s world first development and mass production products are becoming the LED industry standard and leading the global market with a package-free LED, WICOP; a high-voltage AC-driven LED, Acrich; an LED with 10X the output of a conventional LED, nPola; a cutting edge ultraviolet clean technology LED, Violeds; an all-direction light emitting technology, filament LED; a natural sun spectrum LED, SunLike; and more. For more information, please visit www.seoulsemicon.com/en, YouTube, LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240903349776/en/

CONTACT

Seoul Semiconductor Co., Ltd.

Jinseop Jung

jjs8732@seoulsemicon.com

同じカテゴリーの記事 

  • Data from a Phase 1 Trial of HighField Biopharmaceuticals’ HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers
  • DS-9606 Shows Promising Preliminary Clinical Activity in Patients with Advanced Solid Tumors
  • First of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera’s Ability to Predict Overall Survival
  • Latest Data of InnoCare’s Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2024
  • ENHERTU® Showed Substantial Clinical Activity in Patients with HER2 Positive Metastatic Breast Cancer and Brain Metastases